• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特比萘芬对甲癣致病皮肤癣菌和短帚霉的药敏模式。

Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.

作者信息

Carrillo-Muñoz Alfonso-Javier, Giusiano Gustavo, Cárdenes Delia, Hernández-Molina Juan-Manuel, Eraso Elena, Quindós Guillermo, Guardia Celia, del Valle Oscar, Tur-Tur Cristina, Guarro Josep

机构信息

Departamento de Microbiología, ACIA, P.O. Box 10178, E-08080 Barcelona, Spain.

出版信息

Int J Antimicrob Agents. 2008 Jun;31(6):540-3. doi: 10.1016/j.ijantimicag.2008.01.023. Epub 2008 Mar 25.

DOI:10.1016/j.ijantimicag.2008.01.023
PMID:18367383
Abstract

The in vitro antifungal activity of terbinafine against 521 clinical isolates of seven species of dermatophytes, including four onychomycosis-causative species, as well as five Scopulariopsis brevicaulis isolates was determined by a modified Clinical and Laboratory Standards Institute microdilution method. Results showed a high antifungal activity of terbinafine against all dermatophyte isolates (geometric minimal inhibitory concentration (MIC)=0.026 microg/mL; concentration inhibiting 50% of mycological growth (MIC50)=0.03 microg/mL; and concentration inhibiting 90% of mycological growth (MIC90)=0.06 microg/mL). The geometric mean MICs against onychomycosis-causative dermatophyte species was lower (0.024 microg/mL) than the global MIC. However, the in vitro activity of terbinafine against S. brevicaulis was considerably lower (geometric mean MIC=1.38 microg/mL) in comparison with dermatophytes. The antifungal activity of itraconazole was lower than that of terbinafine against these fungi. These data confirm the high in vitro antifungal activity of terbinafine against dermatophytes, under standardised conditions.

摘要

采用改良的美国临床和实验室标准协会微量稀释法,测定了特比萘芬对包括4种引起甲癣的菌种在内的7种皮肤癣菌的521株临床分离株以及5株短帚霉分离株的体外抗真菌活性。结果显示,特比萘芬对所有皮肤癣菌分离株均具有较高的抗真菌活性(几何最低抑菌浓度(MIC)=0.026μg/mL;抑制50%真菌生长的浓度(MIC50)=0.03μg/mL;抑制90%真菌生长的浓度(MIC90)=0.06μg/mL)。特比萘芬对引起甲癣的皮肤癣菌菌种的几何平均MIC较低(0.024μg/mL),低于总体MIC。然而,与皮肤癣菌相比,特比萘芬对短帚霉的体外活性相当低(几何平均MIC=1.38μg/mL)。伊曲康唑对这些真菌的抗真菌活性低于特比萘芬。这些数据证实了在标准化条件下,特比萘芬对皮肤癣菌具有较高的体外抗真菌活性。

相似文献

1
Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.特比萘芬对甲癣致病皮肤癣菌和短帚霉的药敏模式。
Int J Antimicrob Agents. 2008 Jun;31(6):540-3. doi: 10.1016/j.ijantimicag.2008.01.023. Epub 2008 Mar 25.
2
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.伏立康唑对皮肤癣菌、短帚霉及其他引起甲真菌病的机会性真菌的体外活性。
Int J Antimicrob Agents. 2007 Aug;30(2):157-61. doi: 10.1016/j.ijantimicag.2007.04.004. Epub 2007 Jun 6.
3
In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.引起甲癣的皮肤癣菌菌株的体外抗真菌药敏模式
Clin Exp Dermatol. 2007 Nov;32(6):675-9. doi: 10.1111/j.1365-2230.2007.02480.x. Epub 2007 Aug 22.
4
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.体外抗真菌药物氟康唑、伊曲康唑、伏立康唑和特比萘芬治疗甲真菌病的活性。
Clin Exp Dermatol. 2010 Aug;35(6):658-63. doi: 10.1111/j.1365-2230.2009.03698.x. Epub 2009 Oct 23.
5
Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.采用肉汤微量稀释法测定伊曲康唑、特比萘芬和酮康唑对皮肤癣菌的最低抑菌浓度。
Indian J Med Microbiol. 2015 Oct-Dec;33(4):533-7. doi: 10.4103/0255-0857.167341.
6
Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.特比萘芬和伊曲康唑的杀菌与抑菌活性:体外比较
J Am Acad Dermatol. 1998 May;38(5 Pt 3):S37-41. doi: 10.1016/s0190-9622(98)70482-7.
7
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.特比萘芬对具有医学重要性的丝状真菌非皮肤癣菌属菌种的体外活性。
J Antimicrob Chemother. 2004 Jun;53(6):1086-9. doi: 10.1093/jac/dkh228. Epub 2004 Apr 21.
8
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.泊沙康唑、雷夫康唑、特比萘芬、伊曲康唑和氟康唑对皮肤癣菌、酵母菌及非皮肤癣菌属的体外活性。
Med Mycol. 2005 Mar;43(2):179-85. doi: 10.1080/13693780410001731583.
9
[Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].两性霉素B对皮肤癣菌和短帚霉是否有活性?
Rev Esp Quimioter. 2004 Sep;17(3):244-9.
10
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.环吡酮、特比萘芬、酮康唑和伊曲康唑对皮肤癣菌和非皮肤癣菌的体外药敏试验以及联合抗真菌活性的体外评估。
Br J Dermatol. 2003 Aug;149(2):296-305. doi: 10.1046/j.1365-2133.2003.05418.x.

引用本文的文献

1
[Scopulariopsis brevicaulis : The "arsenic fungus"-a difficult-to-treat pathogen].短帚霉:“砷真菌”——一种难以治疗的病原体
Dermatologie (Heidelb). 2025 Jun 25. doi: 10.1007/s00105-025-05526-9.
2
Comparative Analysis of Susceptibility Profile of Dermatophytes Against 8 Antifungal Agents: A Cross-Sectional Study.皮肤癣菌对8种抗真菌药物敏感性概况的比较分析:一项横断面研究。
Indian J Dermatol. 2025 May-Jun;70(3):117-124. doi: 10.4103/ijd.ijd_647_23. Epub 2025 May 8.
3
Antifungals: From Pharmacokinetics to Clinical Practice.抗真菌药物:从药代动力学到临床实践
Antibiotics (Basel). 2023 May 9;12(5):884. doi: 10.3390/antibiotics12050884.
4
Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model.抗真菌药物对真菌孢子的疗效:使用微孔板激光散射浊度法和人工感染的 3D 皮肤模型进行的体外研究。
Microbiologyopen. 2022 Feb;11(1):e1257. doi: 10.1002/mbo3.1257.
5
Anti-fungal potential of ozone against some dermatophytes.臭氧对某些皮肤癣菌的抗真菌潜力。
Braz J Microbiol. 2016 Jul-Sep;47(3):697-702. doi: 10.1016/j.bjm.2016.04.014. Epub 2016 Apr 21.
6
Dermatophytes and other associated fungi in patients attending to some hospitals in Egypt.埃及一些医院就诊患者中的皮肤癣菌及其他相关真菌
Braz J Microbiol. 2015 Jul 1;46(3):799-805. doi: 10.1590/S1517-838246320140615. eCollection 2015 Jul-Sep.
7
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.体外抗真菌药物三联疗法治疗临床帚霉属和皮壳霉属物种。
Antimicrob Agents Chemother. 2015 Aug;59(8):5040-3. doi: 10.1128/AAC.00145-15. Epub 2015 May 26.
8
Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine.以菌丝生长抑制率为标准评估体外特比萘芬、灰黄霉素和环吡酮胺对须癣毛癣菌的敏感性。
Mycopathologia. 2011 Oct;172(4):279-85. doi: 10.1007/s11046-011-9433-7. Epub 2011 May 25.